Lee Hwan-kyung's Gasigogi: Why This Korean Director Just Bet Everything on Indonesian Cinema
At the Cannes Film Market in May 2026, Lee Hwan-kyung — the South Korean director whose Miracle in Cell No. 7 made audiences weep from Seoul to Jakarta — announced his next film with Jakarta's Falcon Pictures. The project is called Gasigogi. And if you're paying attention to where Asian cinema is actually headed, this matters more than the trade headlines suggest.
TL;DR: Lee Hwan-kyung is directing Gasigogi for Indonesian producer Falcon Pictures, shooting begins in coming months, no release date or platform confirmed yet — but expect fierce competition between Netflix and Prime Video for streaming rights. The film follows a father with an intellectual disability who must prove his innocence after being jailed for a commander's child's death, separated from his own daughter.
The Story Behind the Title — and Why Lee Avoided It for Years
The stickleback fish. That's what Gasigogi means.
Male sticklebacks guard fertilized eggs alone. They aerate the nest. They ward off predators. And when their bodies finally fail, their offspring eat them first. It's not metaphorical. It's biology, and Lee Hwan-kyung has built a film around it.
"I avoided this story for years because the weight of it was so painful," Lee told Variety. That's not standard director talk. Most filmmakers rationalize their choices with craft language. Lee just admitted the emotional cost, which tells you something about how personally he's taking this project.
What's striking is the setting. Indonesia, not Korea. Not a remake of his own material, though the 2022 Indonesian remake of Miracle in Cell No. 7, also produced by Falcon Pictures, is the direct through-line to this collaboration. Lee watched how Falcon treated his original story. That trust built Gasigogi.
He's also been specific about something rarer: the film is dedicated to his son, where Miracle was a tribute to his daughter. This isn't a sequel or a thematic echo. It's the other half of something personal.
Why Falcon Pictures Became the Only Studio for This Film
"For a story this intimate, I sought a partnership built on emotional resonance rather than just commercial scale," Lee said, singling out producers Frederica and HB Naveen by name. Specificity like that signals conviction. Directors don't usually explain why they picked a studio. That kind of detail means he's not treating Gasigogi as a career move.
Here's what's actually happening structurally: Korean filmmaking has spent a decade exporting its emotional grammar globally — Parasite, K-drama dominance on Netflix, the whole ecosystem. What gets less attention is the reverse current. Indonesia's 270-million-person market and expanding theatrical infrastructure aren't just distribution territories anymore. They're genuine co-production partners.
Most trade coverage frames this as a simple cross-border collaboration; the more interesting question is whether Gasigogi signals that the gravity center of Asian prestige cinema is shifting south, away from Seoul and toward a Southeast Asian production corridor that Hollywood's streamers haven't fully priced in yet. Falcon's remake of Miracle didn't just perform well commercially. It proved a local production company could handle emotionally complex Korean source material with sophistication. That's the foundation Gasigogi rests on — a Korean director making an Indonesian film, not a Korean film shot in Indonesia.
What We Know (and Don't) About Production
| Key Detail | Status | |---|---| | Director | Lee Hwan-kyung (Miracle in Cell No. 7, 2013) | | Studio | Falcon Pictures, Jakarta | | Producers | Frederica and HB Naveen | | Language | Indonesian | | Shoot start | Coming months (as of May 2026) | | Cast | Not announced | | Runtime | TBD | | Release date | Not announced | | Streaming home | Not announced |
No platform has been attached yet. No theatrical distributor has been named. Hard to say if negotiations are ongoing or if they haven't started in earnest; the project's still early enough that both are plausible.
What we do know: Lee's original Miracle in Cell No. 7 (2013) earned over $59 million at the Korean box office alone, making it one of the highest-grossing domestic Korean releases that year. But here's the number that doesn't get cited enough: the film drew 12.81 million admissions in South Korea (per KOFIC data), placing it among the top ten most-attended Korean films of all time, ahead of The Host and Veteran. The Indonesian remake then pulled comparable audience scale across Southeast Asia, reportedly crossing 8 million viewers domestically. Those numbers matter. They mean any platform acquiring Gasigogi is betting on real audience appetite, not just prestige.
Miracle in Cell No. 7 — The Film That Built This Moment
If you haven't seen the original, here's what you need to know: it's one of the most devastatingly precise emotional films to come out of Korean cinema in two decades. The premise — a father with intellectual disability, wrongfully imprisoned for a police commander's child's death, separated from his daughter — could collapse into manipulation. Instead, Lee threads the needle between heartbreak and warmth with a precision most directors chase their entire careers.
Think about the scene where Yong-gu finally gets to hold Ye-seung inside the cell, the camera holding on Ryu Seung-ryong's face for what feels like a full minute, the score pulling back to near silence. That restraint is the craft. Lee doesn't sentimentalize disability or poverty or imprisonment. He just shows what it costs to love someone when the system is designed to keep you apart. That's the through-line to Gasigogi — same thematic core, different cultural context, different son instead of daughter.
Movie OTT has streaming availability tracked across regions for the original if you want to catch up before Gasigogi lands.
How Gasigogi Will Likely Reach Indian Audiences
India's the wildcard in Gasigogi's release strategy. The original Miracle in Cell No. 7 found passionate audiences on Indian streaming platforms, particularly among viewers already embedded in K-drama through Netflix. The Indonesian remake performed similarly.
For Indian viewers, here's what's realistic:
- Netflix India — most probable. They've got the existing relationship with Korean prestige content and growing investment in Southeast Asian originals
- Amazon Prime Video India — strong secondary possibility, especially if Falcon negotiates regional rights separately
- Disney+ Hotstar — less likely unless a theatrical distributor with Hotstar ties picks up Indian rights
- SonyLIV / ZEE5 / JioCinema — possible for dubbed or subtitled versions if the film performs well theatrically in Indonesia first
The emotional register of Gasigogi — paternal sacrifice, family separation, communal faith — maps almost directly onto what drives the highest-performing content in the Indian OTT market. That's not coincidence. It's an opportunity.
Dubbed tracks in Hindi, Tamil, or Telugu haven't been announced, but the original Miracle did get dubbed versions for Indian platforms. Movie OTT's where-to-watch tracker will have the full regional picture once deals confirm.
What to Watch For as Shooting Begins
A first trailer should land somewhere in late 2026 or early 2027. Festival strategy is the first real signal of how Falcon and Lee are positioning the film. A Cannes or Venice slot confirms international prestige ambitions. Toronto would suggest a North American distribution play. A domestic Indonesia release-first would tell a completely different story.
Cast announcements are the most immediate tell. Lee's choice of lead actor — Korean, Indonesian, or some combination — will define the film's commercial ceiling and festival identity almost immediately. Frederica and HB Naveen have shown with the Miracle remake they can attract serious talent.
Here's my honest take: the bigger question isn't whether Gasigogi will be good. Given Lee's track record and the sincerity radiating from every public statement, it almost certainly will be. The real test is whether the global streaming ecosystem has matured enough to give an Indonesian-language film (not Korean, not English, not a remake) the platform placement it deserves. That's what this project will actually measure in 2027.
Movie OTT will track platform announcements and regional availability as deals develop. Subscribe for updates.
Watch the official trailer:
